# MiNK Therapeutics, Inc.: Form 8-K, filed Oct 17, 2023

- Company: [MiNK Therapeutics, Inc.](/companies/inkt.md) (CIK 1840229)
- Form: 8-K
- Filed: 2023-10-17
- Accepted by EDGAR: Oct 17, 2023, 20:15 ET
- Period: 2023-10-12
- Accession: 0000950170-23-053752
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840229/000095017023053752/inkt-20231012.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840229/000095017023053752/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840229/000095017023053752/inkt-20231012.htm

Filed Oct 17, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-053752. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.